Establishment Labs Holdings (ESTA) EBIT Growth (3y) (2020 - 2026)
Establishment Labs Holdings (ESTA) EBIT Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 3.16% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 19.80% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 31.84% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.88% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 35.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.04% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 60.19% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 13.06% |
| 10 | Establishment Labs Holdings | 2.16 Bn | 2.09 Bn | 47.71 Mn | 32.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 32.11% |
| Mar 31, 2026 | 7.25% |
| Dec 31, 2025 | 33.16% |
| Sep 30, 2025 | 27.40% |
| Jun 30, 2025 | -10.68% |
| Mar 31, 2025 | -44.86% |
| Dec 31, 2024 | -25.85% |
| Sep 30, 2024 | -13.26% |
| Jun 30, 2024 | -26.34% |
| Mar 31, 2024 | -61.53% |
| Dec 31, 2023 | -40.25% |
| Sep 30, 2023 | -100.99% |
| Jun 30, 2023 | -12.61% |
| Mar 31, 2023 | -1.93% |
| Dec 31, 2022 | -44.02% |
| Sep 30, 2022 | -6.26% |
| Jun 30, 2022 | -3.51% |
| Mar 31, 2022 | 12.73% |
| Dec 31, 2021 | -2.80% |
| Sep 30, 2021 | -14.37% |